NONG Zhi-xin, ZHAO Shi-yuan, ZHANG Ming-yan, et al. Antitumor Effects of Steroidal Saponins of (SSCN) on Human Hepatocellular Carcinoma Xenografts in Nude Mice[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(17): 239-243.
NONG Zhi-xin, ZHAO Shi-yuan, ZHANG Ming-yan, et al. Antitumor Effects of Steroidal Saponins of (SSCN) on Human Hepatocellular Carcinoma Xenografts in Nude Mice[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(17): 239-243. DOI: 10.11653/syfj2013170239.
Objective: To investigate the antitumor effects and mechanism of steroidal saponins of Cestrum nocturnum(SSCN) on human hepatocellular carcinoma xenografts in nude mice in vivo. Method: SSCN from the leaves and twigs of cestrum nocturnum
Linn were separated and their structures were identified by solvent;the animal model of human hepatocellular carcinoma xenografts was constructed by subcutaneous inoculation of hepatocellular carcinoma HepG2 cells into nude mice.The mice were randomly divided into five groups:NS group(0.2 mL)
thalidomide(TLD) group(200 mg·kg-1)
and SSCN low
medium and high dose groups(4
6
8 mg·kg-1).During treatment
tumor size was measured.The mice were killed 30 days later to observe tumor morphology.The angiogenesis was assessed by immunohistochemical staining using anti-vascular endothelia grouth factor(VEGF) and cluster of differentiation 34(CD34) antibodies
the expression of interleukin-8(IL-8) of serum was detected by ELISA. Result: The relative proliferation rate in experimental groups (low
medium and high doses) was 48.26%
42.94% and 41.57%
respectively
and in positive group (thalidomide) the relative proliferation rate was 42.19%. Compared with the NS group
the expression of MVD
VEGF and IL-8 were was markedly lowered in all SSCN treatment groups and TLD group (P<0.01). Conclusion: SSCN has a certain inhibitory effect on tumor nude mice in vivo. The anti-tumor mechanism is probably related to the inhibition of activity of VEGF
MVD and IL-8
and downregulating the expression of proangiogenic factors.